The Open UniversitySkip to content

Enteral feeding reduces metabolic activity of the intestinal microbiome in Crohn’s disease: an observational study

Walton, C; Montoya, M P B; Fowler, D P; Turner, C; Jia, W; Whitehead, R N; Griffiths, L; Waring, R H; Ramsden, D B; Cole, J A; Cauchi, M; Bessant, C; Naylor, S J and Hunter, J O (2016). Enteral feeding reduces metabolic activity of the intestinal microbiome in Crohn’s disease: an observational study. European Journal of Clinical Nutrition, 70 pp. 1052–1056.

Full text available as:
PDF (Accepted Manuscript) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Download (318kB) | Preview
DOI (Digital Object Identifier) Link:
Google Scholar: Look up in Google Scholar


Enteral feeding will induce remission in as many as 80–90% of compliant patients with active Crohn’s disease (CD), but its method of action remains uncertain. This study was designed to examine its effects on the colonic microbiome.

Healthy volunteers and patients with CD followed a regimen confined to enteral feeds alone for 1 or 2 weeks, respectively. Chemicals excreted on breath or in faeces were characterised at the start and at the end of the feeding period by gas chromatography/mass spectrometry.

One week of feeding in healthy volunteers caused significant changes in stool colour and deterioration in breath odour, together with increased excretion of phenol and indoles on the breath. Feeding for 2 weeks in patients with CD produced significant improvements in symptoms and a decrease in the concentration of C-reactive protein. The faecal concentrations of microbial products, including short-chain fatty acids (SCFAs), and potentially toxic substances, including 1-propanol, 1-butanol and the methyl and ethyl esters of SCFAs, showed significant falls.

A significant change occurs in the production of microbial metabolites after enteral feeding in both healthy volunteers and patients with CD. Many of those detected in CD are toxic and may feasibly lead to the immunological attack on the gut microbiota, which is characteristic of inflammatory bowel disease. The reduction in the production of such metabolites after enteral feeding may be the reason for its effectiveness in CD.

Item Type: Journal Item
Copyright Holders: 2016, Rights Managed by Nature Publishing Group
ISSN: 0954-3007
Project Funding Details:
Funded Project NameProject IDFunding Body
Sulphate metabolism in inflammatory bowel disease080238/Z/06/ZWellcome Trust
Keywords: Crohn’s disease; enteral feeding; nutrition; colonic microflora; metabolomics; breath analysis; faecal analysis; enterometabolic disorder; E028 extra; Modulen IBD
Academic Unit/School: Faculty of Science, Technology, Engineering and Mathematics (STEM) > Life, Health and Chemical Sciences
Faculty of Science, Technology, Engineering and Mathematics (STEM)
Research Group: Innovation, Knowledge & Development research centre (IKD)
Item ID: 46292
Depositing User: Claire Turner
Date Deposited: 13 May 2016 09:55
Last Modified: 15 Jan 2020 04:46
Share this page:


Altmetrics from Altmetric

Citations from Dimensions

Download history for this item

These details should be considered as only a guide to the number of downloads performed manually. Algorithmic methods have been applied in an attempt to remove automated downloads from the displayed statistics but no guarantee can be made as to the accuracy of the figures.

Actions (login may be required)

Policies | Disclaimer

© The Open University   contact the OU